ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 199,71
0,00%
Dow Jones
43 191,24
-1,48%
DAX
23 147,02
2,90%
Brent Oil
70,895
-0,71%
Bitcoin
83 525,25
-2,98%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Catalyst Pharmaceuticals Inc (CPRX) Cours

Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc (CPRX)

NASDAQ
22,32
-0,57
(-2,49%)
Fermé 04 Mars 10:00PM
Retardé de 15 minutes
22,80
0,48
(2,15%)
Après les heures de négociation: 1:55AM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
22,80
Prix Achat
21,11
Prix Vente
23,40
Volume échangé
1 526 642
22,27 Fourchette du Jour 23,3882
14,47 Plage de 52 semaines 24,64
Cap du marché
2,769B
Clôture Veille
22,89
Ouverture
22,89
Dernière Transaction
1
@
22.21
Dernière heure de transaction
Volume financier
US$ 35 034 252
VWAP
22,9486
Volume moyen (3 m)
1 127 451
Actions en circulation
121 449 655
Rendement du Dividende
-
Ratio Cours sur Bénéfices
37,99
Bénéfice par action (BPA)
0,59
Chiffre d'affairess
398,2M
Bénéfice net
71,41M

À propos de Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of p... Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.catalystpharma.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Catalyst Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker CPRX. Le dernier cours de clôture d'Catalyst Pharmaceuticals était de US$22,89. Au cours de la dernière année, les actions de Catalyst Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 14,47 à US$ 24,64.

Catalyst Pharmaceuticals compte actuellement 121 449 655 actions en circulation. La capitalisation boursière d'Catalyst Pharmaceuticals est de US$2,78 milliard. Catalyst Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de 37.99.

Flux d'options Catalyst Pharmaceuticals (CPRX)

Voir le flux d'options complet

Flux global

Haussier

Prime nette

27k

Calls / Puts

100,00%

Ach. / Vent.

0,00%

OTM / ITM

100,00%

Sweeps Ratio

0,00%

CPRX Dernières nouvelles

Plus de nouvelles

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
il y a 10 heures
CPRX (-2,49%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
il y a 16 heures
CPRX (-2,49%)

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
Edgar (US Regulatory)
28 Février 2025
CPRX (-2,49%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
26 Février 2025
CPRX (-2,49%)

Form 8-K - Current report
Edgar (US Regulatory)
26 Février 2025
CPRX (-2,49%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
26 Février 2025
CPRX (-2,49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 Février 2025
CPRX (-2,49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 Février 2025
CPRX (-2,49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 Février 2025
CPRX (-2,49%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.356.2937062937121.4523.54520.46155737021.500056CS
40.512.2880215343222.2923.7420.46104926622.27684838CS
120.632.8416779431722.1724.6419.15112745122.15739895CS
262.6112.92719167920.1924.6419102348621.67119804CS
525.5732.327336041817.2324.6414.47108719518.84548122CS
15614.67180.4428044288.1324.646.15162369114.86209354CS
26018.36413.5135135144.4424.642.55156446910.90122057CS

CPRX - Frequently Asked Questions (FAQ)

What is the current Catalyst Pharmaceuticals share price?
The current share price of Catalyst Pharmaceuticals is US$ 22,80
How many Catalyst Pharmaceuticals shares are in issue?
Catalyst Pharmaceuticals has 121 449 655 shares in issue
What is the market cap of Catalyst Pharmaceuticals?
The market capitalisation of Catalyst Pharmaceuticals is USD 2,78B
What is the 1 year trading range for Catalyst Pharmaceuticals share price?
Catalyst Pharmaceuticals has traded in the range of US$ 14,47 to US$ 24,64 during the past year
What is the PE ratio of Catalyst Pharmaceuticals?
The price to earnings ratio of Catalyst Pharmaceuticals is 37,99
What is the cash to sales ratio of Catalyst Pharmaceuticals?
The cash to sales ratio of Catalyst Pharmaceuticals is 6,81
What is the reporting currency for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Catalyst Pharmaceuticals?
The latest annual turnover of Catalyst Pharmaceuticals is USD 398,2M
What is the latest annual profit for Catalyst Pharmaceuticals?
The latest annual profit of Catalyst Pharmaceuticals is USD 71,41M
What is the registered address of Catalyst Pharmaceuticals?
The registered address for Catalyst Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Catalyst Pharmaceuticals website address?
The website address for Catalyst Pharmaceuticals is www.catalystpharma.com
Which industry sector does Catalyst Pharmaceuticals operate in?
Catalyst Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ACONAclarion Inc
US$ 7,511
(124,21%)
89,21M
BTOGBit Origin Ltd
US$ 0,3209
(76,32%)
291,2M
BTAIBioXcel Therapeutics Inc
US$ 3,73
(72,69%)
146,85M
CLROClearOne Inc
US$ 0,78
(50,87%)
33,41M
ATLNAtlantic International Corporation
US$ 3,1674
(50,11%)
615,54k
BLNEEastside Distilling Inc
US$ 0,7237
(-90,57%)
51,81k
NVNINVNI Group Ltd
US$ 0,3798
(-62,40%)
37,83M
AGMHAGM Group Holdings Inc
US$ 0,1304
(-60,32%)
9,41M
PLRXPliant Therapeutics Inc
US$ 1,38
(-59,88%)
19,45M
AGHAureus Greenway Holdings Inc
US$ 2,23
(-59,01%)
3,79M
NVDANVIDIA Corporation
US$ 114,06
(-8,69%)
409,42M
BTOGBit Origin Ltd
US$ 0,3209
(76,32%)
291,2M
FTFTFuture FinTech Group Inc
US$ 0,249
(23,27%)
218,59M
SPGCSacks Parente Golf Inc
US$ 0,187
(-10,35%)
160,53M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 12,6667
(-5,82%)
153,57M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CPRX
Catalyst Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces